However, the Food and Health agency (FDA) from the United States has repeatedly notified the company due to problems such as low-skilled workers, cracked bottles and mold problems and other types of contamination around one of its facilities, according to records obtained by the AP covering inspections as of 2017.
Johnson & Johnson said on Wednesday that a batch of vaccines made by Emergent BioSolutions at its Baltimore, Northeastern Maryland plant, it cannot be used because it does not have the proper quality standards.
It is not clear how the problem will affect the future distribution of J&J vaccines, with the company stating in a statement that it still plans to deliver 100 million doses by the end of June.
J&J signed a partnership with Emergent BioSolutions in April 2020, enlisting the lesser-known company to make the vaccine from US tax dollars.
At the time, the Baltimore plant was not scheduled to produce millions of doses of a potential vaccine for covid-19, according to the records of the FDA, who describe the facility as a testing laboratory that “did not manufacture products for distribution”.
A FDA inspected the factory in April 2020, criticizing the company for problems with its testing for a potential treatment of anthrax, according to the records obtained by the AP.
The principal investigator of AP said that the company failed to train employees “in the specific operations they carry out as part of their role and current standards of good manufacturing”.
White House press officer Jen Psaki, said today that none of the doses currently on the market were affected and that the company is expected to deliver 24 million doses in April.
A pandemic from covid-19 caused at least 2,816,908 deaths worldwide, resulting from more than 128.8 million cases of infection, according to a report made by the French agency AFP.
The United States recorded 1,055 deaths from covid-19 in the last 24 hours, in addition to 66,088 new cases, according to the independent count by the North American University Johns Hopkins.
The disease is transmitted by a new coronavirus detected at the end of 2019, in Wuhan, a city in central China.
Always be the first to know.
Fifth consecutive year Consumer Choice for Online Press.
Download our free App.
Get the latest news delivered to your inbox
Follow us on social media networks